Last kr215.50 SEK
Change Today -0.50 / -0.23%
Volume 4.1K
As of 8:23 AM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

biogaia ab-b shs (BIOGB) Snapshot

Open
kr215.00
Previous Close
kr216.00
Day High
kr216.00
Day Low
kr214.00
52 Week High
02/16/15 - kr224.00
52 Week Low
10/13/14 - kr151.00
Market Cap
3.7B
Average Volume 10 Days
39.8K
EPS TTM
kr8.54
Shares Outstanding
16.5M
EX-Date
05/8/15
P/E TM
25.2x
Dividend
kr3.46
Dividend Yield
3.24%
Current Stock Chart for BIOGAIA AB-B SHS (BIOGB)

Related News

No related news articles were found.

biogaia ab-b shs (BIOGB) Related Businessweek News

No Related Businessweek News Found

biogaia ab-b shs (BIOGB) Details

BioGaia AB develops, markets, and sells probiotic products with documented health benefits worldwide. The company operates through Finished Consumer Products, Component Products, and Other Products segments. It offers products for the treatment of acute diarrhoea, constipation, helicobacter pylori infection, infant colic, regurgitation, and gingivitis, as well as for digestive and oral health. The company provides BioGaia ProTectis digestive health probiotic drops, as well as BioGaia ProTectis D3 drops with vitamin D3 containing lactobacillus reuteri protectis for children; and BioGaia ProTectis ORS, a probiotic oral rehydration solution with zinc. It also offers BioGaia ProTectis chewable tablet, a dietary supplement containing lactobacillus reuteri protectis, as well as BioGaia ProDentis oral lozenges, a dietary supplement containing lactobacillus reuteri prodentis for adults and children; BioGaia Gastrus, a probiotic supplement that could enhance treatment of Helicobacter pylori infection; and BioGaia ProTectis straw that provides lactobacillus reuteri protectis to various beverages. In addition, the company offers ProDentis oral health tablet for the treatment of periodontal disease and gingivitis; and component products, which are bacterial cultures of lactobacillus reuteri protectis that are used as ingredients in infant formula and cereal products, yoghurt, and other dairy products. Further, it provides animal health products. The company sells its products through pharmacies and related outlets. BioGaia AB was founded in 1990 and is headquartered in Stockholm, Sweden.

95 Employees
Last Reported Date: 02/12/15
Founded in 1990

biogaia ab-b shs (BIOGB) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

biogaia ab-b shs (BIOGB) Key Developments

BioGaia AB Reports Group Earnings Results for the Fourth Quarter and Group and Parent Earnings Results for the Year Ended December 31, 2014

BioGaia AB reported group earnings results for the fourth quarter and group and parent earnings results for the year ended December 31, 2014. For the quarter, the group reported net sales of SEK 121,374,000 compared with SEK 90,221,000 for the same period last year. Operating profit was SEK 30,560,000 compared with SEK 23,773,000 for the same period last year. Interest income was SEK 246,000 compared with SEK 1,165,000 for the same period last year. Profit for the period attributable to owners of the parent company was SEK 17,889,000 or SEK 1.04 diluted per share compared with SEK 16,300,000 or SEK 0.94 diluted per share for the same period last year. Negative cash flow from operating activities was SEK 3,317,000 compared with SEK 2,045,000 for the same period last year. For the full year, the group reported net sales of SEK 386,405,000 compared with SEK 315,875,000 for the same period last year. Operating profit was SEK 196,883,000 compared with SEK 81,653,000 for the same period last year. Interest income was SEK 2,382,000 compared with SEK 5,081,000 for the same period last year. Profit for the period attributable to owners of the parent company was SEK 147,406,000 or SEK 8.53 diluted per share compared with SEK 61,722,000 or SEK 3.56 diluted per share for the same period last year. Cash flow from operating activities was SEK 124,383,000 compared with SEK 78,441,000 for the same period last year. Return on average equity was 45% compared with 16% for the same period last year. For the year, the parent reported net sales of SEK 368,809,000 compared with SEK 304,624,000 for the same period last year. Operating profit was SEK 201,945,000 compared with SEK 84,155,000 for the same period last year. Profit before tax was SEK 192,625,000 compared with SEK 186,261,000 for the same period last year. Profit for the period was SEK 149,590,000 compared with SEK 144,657,000 for the same period last year. Cash flow from operating activities was SEK 121,772,000 compared with SEK 73,764,000 for the same period last year.

BioGaia AB, 2014 Earnings Call, Feb 12, 2015

BioGaia AB, 2014 Earnings Call, Feb 12, 2015

BioGaia Signs an Exclusive Agreement with VietPhap International

BioGaia announced that it has signed an exclusive agreement with VietPhap International Co Ltd. for the rights to sell BioGaia ProTectis Drops in Vietnam. The launch is planned to take place during 2015. VietPhap will market BioGaia ProTectis Baby Drops, and later also launch BioGaia ProTectis Baby Drops with vitamin D. Both products contain the patented and well-documented probiotic strain Lactobacillus reuteri Protectis.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIOGB:SS kr215.50 SEK -0.50

BIOGB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BLIS Technologies Ltd $0.02 NZD 0.00
Danone SA €62.07 EUR +0.22
Novartis AG SFr.97.60 CHF -0.55
Oragenics Inc $1.15 USD -0.0117
Yakult Honsha Co Ltd ¥7,580 JPY +90.00
View Industry Companies
 

Industry Analysis

BIOGB

Industry Average

Valuation BIOGB Industry Range
Price/Earnings 24.3x
Price/Sales 7.4x
Price/Book 10.4x
Price/Cash Flow 23.2x
TEV/Sales 6.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOGAIA AB-B SHS, please visit www.biogaia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.